Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Third-party MSC Infusion After Renal or Liver Transplantation
NCT01429038Phase 2Completed
- Sponsor
- University of Liège
- Start
- Feb 2012
- Primary completion
- Mar 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in graft rejection, sponsored by University of Liège. Started Feb 2012; status: completed.
02
Drugs
mesenchymal stem cells
03
Conditions
graft rejection
Beyond the preview
Go deeper on NCT01429038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01429038.